Login to Your Account



Going 'Above and Beyond Aesthetics'

Ear, Ear: Fibrocell Placement Adds $45M to Boost LaViv

By Randy Osborne
BioWorld Today Contributing Writer

Monday, October 8, 2012
Fibrocell Science Inc. wants to use $45 million from a private placement to reach more customers with LaViv (azficel-T), the personalized wrinkle therapy that harvests a sample of the patient's own cells by way of a skin-punch behind the ear, expands their collagen-making fibroblasts in the laboratory, and returns them by injection to nasolabial folds.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription